Therapeutics Acquisition Corp. – NASDAQ:RACA

Therapeutics Acquisition Corp. stock price today

$10.274

Therapeutics Acquisition Corp. stock price monthly change

+17.55%
month

Therapeutics Acquisition Corp. stock price quarterly change

+21.30%
quarter

Therapeutics Acquisition Corp. stock price yearly change

-25.55%
year

Therapeutics Acquisition Corp. key metrics

Market Cap
 1.08B
Enterprise value
 39.69M
P/E
 -2.48
EV/Sales
 N/A
EV/EBITDA
 -2.51
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -4.05
Revenue
 N/A
EBITDA
 -16.17M
Income
 -15.67M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Therapeutics Acquisition Corp. stock price history

Therapeutics Acquisition Corp. stock forecast

Therapeutics Acquisition Corp. financial statements

Profit Margin

Therapeutics Acquisition Corp. (NASDAQ:RACA): Profit margin
Jun 2021 0 -14.26M
RACA income statement history

Debt to Assets

Therapeutics Acquisition Corp. (NASDAQ:RACA): Debt to assets
Apr 2020 115309 102.14K 88.58%
Jun 2020 514142 508.51K 98.9%
Mar 2021 136498092 5.85M 4.29%
Jun 2021 0 0
RACA balance sheet history

Cash Flow

Therapeutics Acquisition Corp. (NASDAQ:RACA): Cash Flow
Jun 2021 -16.83M -5.85M 285.87M
RACA cash flow history

Therapeutics Acquisition Corp. other data

Therapeutics Acquisition Corp.
Insider Trading

Therapeutics Acquisition Corp. (NASDAQ:RACA): Insider trades (number of shares)
Period Buy Sel
Jun 2021 209100 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
RA CAPITAL MANAGEMENT, L.P.
Common Stock 209,100 N/A N/A
RACA insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Therapeutics Acquisition Corp. stock today?

    One share of Therapeutics Acquisition Corp. stock can currently be purchased for approximately $10.27.

  • When is Therapeutics Acquisition Corp.'s next earnings date?

    Unfortunately, Therapeutics Acquisition Corp.'s (RACA) next earnings date is currently unknown.

  • Does Therapeutics Acquisition Corp. pay dividends?

    No, Therapeutics Acquisition Corp. does not pay dividends.

  • How much money does Therapeutics Acquisition Corp. make?

    Therapeutics Acquisition Corp. has a market capitalization of 1.08B.

  • What is Therapeutics Acquisition Corp.'s stock symbol?

    Therapeutics Acquisition Corp. is traded on the NASDAQ under the ticker symbol "RACA".

  • What is Therapeutics Acquisition Corp.'s primary industry?

    Company operates in the Financial Services sector and Shell Companies industry.

  • How do i buy shares of Therapeutics Acquisition Corp.?

    Shares of Therapeutics Acquisition Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Therapeutics Acquisition Corp. went public?

    Therapeutics Acquisition Corp. is publicly traded company for more then 5 years since IPO on 7 Aug 2020.

  • What is Therapeutics Acquisition Corp.'s official website?

    The official website for Therapeutics Acquisition Corp. is researchalliancecorp.com.

  • Where are Therapeutics Acquisition Corp.'s headquarters?

    Therapeutics Acquisition Corp. is headquartered at 200 Berkeley Street, Boston, MA.

  • How can i contact Therapeutics Acquisition Corp.?

    Therapeutics Acquisition Corp.'s mailing address is 200 Berkeley Street, Boston, MA and company can be reached via phone at +61 77782500.

Therapeutics Acquisition Corp. company profile:

Therapeutics Acquisition Corp.

researchalliancecorp.com
Exchange:

NASDAQ

Full time employees:

0

Industry:

Shell Companies

Sector:

Financial Services

Therapeutics Acquisition Corp., doing business as Research Alliance Corp. I, intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry in the United States. The company was founded in 2020 and is based in Boston, Massachusetts.

+61 77782500
200 Berkeley Street
Boston, MA

CIK: 0001811764
:
: